View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNocturne Acquisition 将来の成長Future 基準チェック /06現在、 Nocturne Acquisitionの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Capital Markets 収益成長12.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 20Nocturne Acquisition Expects the Nasdaq Stock Market to File Form 25 with the United States Securities and Exchange Commission to Delist its SecuritiesNocturne Acquisition Corp. (‘Nocturne’ or the ‘Company’) announced that it will be unable to complete an initial business combination with Cognos Therapeutics Inc. (‘Cognos’) and intends to liquidate the Trust Account. In connection with the liquidation of the Trust Account, the Company will redeem all of the outstanding public shares of common stock (the ‘Public Shares’) at a per-share redemption price of approximately $11.79, after taking into account the removal of a portion of the accrued interest in the Trust Account to pay taxes and dissolution expenses. As of the close of business on or about April 18, 2024, the Public Shares will be deemed cancelled and stockholders will have the right to receive the redemption amount. In order to provide for the disbursement of funds from the Trust Account, the Company has instructed Continental Stock Transfer & Trust Company (‘Continental’), the trustee of the Trust Account, to take all necessary actions to liquidate the Trust Account. Record holders will receive their pro rata portion of the proceeds of the Trust Account by delivering their Public Shares to Continental, the Company's transfer agent. Beneficial owners of Public Shares held in ‘street name,’ however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed on or about April 18, 2024. The Company’s sponsor has agreed to waive its redemption rights with respect to its founder shares and private units. The Company expects that the Nasdaq Stock Market LLC will file a Form 25 with the United States Securities and Exchange Commission (the ‘SEC’) to delist the Company’s securities. The Company thereafter expects to file a Form 15 with the SEC to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.お知らせ • Apr 04Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite IndexNocturne Acquisition Corporation has been dropped from NASDAQ Composite Index .お知らせ • Apr 02+ 1 more updateNocturne Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2024, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.Board Change • Mar 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Feb 08Nocturne Acquisition Corporation Announces Management ChangesOn February 1, 2024, Kashan Zaheer Piracha resigned from his position on the Board of Directors of Nocturne Acquisition Corporation, including his service on the Audit Committee of the Board and his chairmanship and service on the Compensation Committee of the Board. Mr. Piracha’s resignation was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices. On February 2, 2024, the Board appointed Haoyu (Liz) Lin, 35, to serve as the Company’s Chief Strategy Officer and to a directorship position on the Board. The Board further appointed current director Ka Lok Wong to replace Mr. Piracha as a member of the Audit Committee and Chairman of the Compensation Committee. Ms. Lin has extensive experience with asset management and wealth management. Ms. Lin has served as Associate Director of Oneplatform Wealth Management Limited, owned by AGBA Group Holding Limited since April 2022. She has also served as Associate Director of OnePlatform Asset Management Limited of the same group since October 2023. Since September 2011, Ms. Lin has served as Associate Director at Convoy Global Holding Ltd. She received her BA from Wuhan University, MA from Hong Kong Baptist University and MBA from Tsinghua University. The Board believes Ms. Lin is well qualified to serve as its director due to her extensive experience in the financial industry.お知らせ • Jan 19Nocturne Acquisition Corporation Receives Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn January 8, 2024, Nocturne Acquisition Corporation (the Company"), received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq") stating that the Company failed to hold an annual meeting of shareholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the Rule"). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until February 22, 2024) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its fiscal year end (or until June 28, 2024) to regain compliance. If Nasdaq does not accept the Company's plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel. The Company intends to submit a compliance plan within the specified period. While the plan is pending, the Company's securities will continue to trade on Nasdaq.お知らせ • Nov 14Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/13/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Board Change • Nov 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Derek Yiyi Feng was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Aug 13Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/11/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 07Nocturne Acquisition Receives Letter from the Listing Qualifications Department Staff of the Nasdaq as the Company No Longer Meets the Minimum 500,000 Publicly Held Shares Required for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(4)On May 31, 2023, Nocturne Acquisition Corporation received a letter (the “Public Float Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it no longer meets the minimum 500,000 publicly held shares required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(4) (the “Public Float Standard”). The Public Float Notice stated that the Company has until July 17, 2023 to provide Nasdaq with a specific plan to achieve and sustain compliance with all Nasdaq Capital Market listing requirements, including the time frame for completion of its plan. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. On April 3, 2023 at the extraordinary general meeting of the Company’s shareholders, the Company, in conjunction with a vote of the shareholders in favor of amending the organizational documents of the Company to extend the amount of time the Company has to complete a combination transaction (the “Extension Vote”), offered its shareholders the right to redeem public shares. The Company is in the process of confirming whether it currently satisfies the Public Float Standard, but believes that if it does not, the redemption of public shares in conjunction with the Extension Vote is what would have caused the Company to no longer be in compliance with the Public Float Standard. If the Company currently does not satisfy the Public Float Standard, it is expected that the surviving company in the Company’s previously announced, pending initial business combination with Cognos Therapeutics Inc. would satisfy the Public Float Standard immediately following the consummation of the initial business combination. The Public Float Notice has no immediate effect on the listing of the Company’s securities, and the Company’s securities continue to trade on the Nasdaq Capital Market. The Company intends to provide Nasdaq, on or prior to July 17, 2023, with the Company’s plan to meet the Public Float Standard, and will evaluate available options to regain compliance with the Public Float Standard. However, there can be no assurance that the Company will be able to regain compliance under the Public Float Standard, or will otherwise be in compliance with other Nasdaq listing criteria.お知らせ • May 31Nocturne Acquisition Announces Receipt of Second Notification from Nasdaq Due to Failure to File its Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a second notification (the ‘Second Notification’) on May 24, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (‘Nasdaq’) as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the ‘Form 10-Q’), and remaining delinquent in filing its Annual Report on Form 10-K for the period ended December 31, 2022 (the ‘Form 10-K’). The Second Notification advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company has since filed its Form 10-K, and is working diligently to complete and file the Form 10-Q as soon as practicable. In accordance with Nasdaq's letter dated April 21, 2023, the Company has until June 20, 2023, to submit a plan to regain compliance with respect to these delinquent reports. Please note that any Staff exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 16, 2023. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.お知らせ • May 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/15/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 04Nocturne Acquisition Corporation Receives Non-Compliance Notice From NasdaqOn April 21, 2023, Nocturne Acquisition Corporation (the “Company”) received a notification from Nasdaq that it was in violation of a Nasdaq continued listing requirement as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”). The notification provided that the Company had 60 days from the date of the letter to submit a plan to regain compliance with this continued listing requirement. The Company intends to file its 10-K imminently and bring itself back into compliance with the Nasdaq continued listing requirements.Board Change • Feb 15High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CFO & Director Thomas Ao is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jan 04Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction.Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction on January 3, 2023. Certain outstanding options and warrants to acquire capital stock of Cognos would be assumed by Nocturne. The transaction has been unanimously approved by the respective boards of directors of Cognos and Nocturne and is subject to approval by stockholders of Nocturne and Cognos and other customary closing conditions. The proposed business combination is expected to be completed in the second or third quarter of 2023. Maxim Group LLC served as sole financial advisor to Cognos in connection with the proposed business combination, and Newbridge Securities Corporation provided independent valuation advisory services to Nocturne. Ellenoff Grossman & Schole LLP served as legal advisor to Cognos and Dechert LLP served as legal advisor to Nocturne.お知らせ • Nov 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 06Nocturne Acquisition Corporation Announces Resignation of Etienne Snyman as Member of the BoardNocturne Acquisition Corporation announced that effective July 4, 2022, Etienne Snyman tendered his resignation as member of the Board. Mr. Snyman resigned due to a disagreement with the Company regarding the completion of the Extension.お知らせ • Jun 05Nocturne Acquisition Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company is working diligently to complete its Form 10-Q. The Company intends to file it as soon as practicable to regain compliance with Nasdaq continued listing standards.お知らせ • May 18Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/17/2021, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Nocturne Acquisition は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測NasdaqCM:MBTC - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/2023N/A-2-2-2N/A6/30/2023N/A-1-2-2N/A3/31/2023N/A-1-2-2N/A12/31/2022N/A-1-1-1N/A9/30/2022N/A-1-1-1N/A6/30/2022N/A-1-1-1N/A12/31/2021N/A-1-1-1N/Aアナリストによる今後の成長予測収入対貯蓄率: MBTCの予測収益成長が 貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: MBTCの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: MBTCの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: MBTCの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: MBTCの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MBTCの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YDiversified-financials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/04/04 01:23終値2024/04/04 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nocturne Acquisition Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 20Nocturne Acquisition Expects the Nasdaq Stock Market to File Form 25 with the United States Securities and Exchange Commission to Delist its SecuritiesNocturne Acquisition Corp. (‘Nocturne’ or the ‘Company’) announced that it will be unable to complete an initial business combination with Cognos Therapeutics Inc. (‘Cognos’) and intends to liquidate the Trust Account. In connection with the liquidation of the Trust Account, the Company will redeem all of the outstanding public shares of common stock (the ‘Public Shares’) at a per-share redemption price of approximately $11.79, after taking into account the removal of a portion of the accrued interest in the Trust Account to pay taxes and dissolution expenses. As of the close of business on or about April 18, 2024, the Public Shares will be deemed cancelled and stockholders will have the right to receive the redemption amount. In order to provide for the disbursement of funds from the Trust Account, the Company has instructed Continental Stock Transfer & Trust Company (‘Continental’), the trustee of the Trust Account, to take all necessary actions to liquidate the Trust Account. Record holders will receive their pro rata portion of the proceeds of the Trust Account by delivering their Public Shares to Continental, the Company's transfer agent. Beneficial owners of Public Shares held in ‘street name,’ however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed on or about April 18, 2024. The Company’s sponsor has agreed to waive its redemption rights with respect to its founder shares and private units. The Company expects that the Nasdaq Stock Market LLC will file a Form 25 with the United States Securities and Exchange Commission (the ‘SEC’) to delist the Company’s securities. The Company thereafter expects to file a Form 15 with the SEC to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.
お知らせ • Apr 04Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite IndexNocturne Acquisition Corporation has been dropped from NASDAQ Composite Index .
お知らせ • Apr 02+ 1 more updateNocturne Acquisition Corporation announced delayed annual 10-K filingOn 04/01/2024, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Board Change • Mar 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chief Strategy Officer & Director Liz Lin was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 08Nocturne Acquisition Corporation Announces Management ChangesOn February 1, 2024, Kashan Zaheer Piracha resigned from his position on the Board of Directors of Nocturne Acquisition Corporation, including his service on the Audit Committee of the Board and his chairmanship and service on the Compensation Committee of the Board. Mr. Piracha’s resignation was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices. On February 2, 2024, the Board appointed Haoyu (Liz) Lin, 35, to serve as the Company’s Chief Strategy Officer and to a directorship position on the Board. The Board further appointed current director Ka Lok Wong to replace Mr. Piracha as a member of the Audit Committee and Chairman of the Compensation Committee. Ms. Lin has extensive experience with asset management and wealth management. Ms. Lin has served as Associate Director of Oneplatform Wealth Management Limited, owned by AGBA Group Holding Limited since April 2022. She has also served as Associate Director of OnePlatform Asset Management Limited of the same group since October 2023. Since September 2011, Ms. Lin has served as Associate Director at Convoy Global Holding Ltd. She received her BA from Wuhan University, MA from Hong Kong Baptist University and MBA from Tsinghua University. The Board believes Ms. Lin is well qualified to serve as its director due to her extensive experience in the financial industry.
お知らせ • Jan 19Nocturne Acquisition Corporation Receives Notice from the Listing Qualifications Department of the Nasdaq Stock MarketOn January 8, 2024, Nocturne Acquisition Corporation (the Company"), received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq") stating that the Company failed to hold an annual meeting of shareholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the Rule"). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until February 22, 2024) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its fiscal year end (or until June 28, 2024) to regain compliance. If Nasdaq does not accept the Company's plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel. The Company intends to submit a compliance plan within the specified period. While the plan is pending, the Company's securities will continue to trade on Nasdaq.
お知らせ • Nov 14Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/13/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Board Change • Nov 11High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Derek Yiyi Feng was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 13Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/11/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 07Nocturne Acquisition Receives Letter from the Listing Qualifications Department Staff of the Nasdaq as the Company No Longer Meets the Minimum 500,000 Publicly Held Shares Required for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(4)On May 31, 2023, Nocturne Acquisition Corporation received a letter (the “Public Float Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it no longer meets the minimum 500,000 publicly held shares required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(4) (the “Public Float Standard”). The Public Float Notice stated that the Company has until July 17, 2023 to provide Nasdaq with a specific plan to achieve and sustain compliance with all Nasdaq Capital Market listing requirements, including the time frame for completion of its plan. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. On April 3, 2023 at the extraordinary general meeting of the Company’s shareholders, the Company, in conjunction with a vote of the shareholders in favor of amending the organizational documents of the Company to extend the amount of time the Company has to complete a combination transaction (the “Extension Vote”), offered its shareholders the right to redeem public shares. The Company is in the process of confirming whether it currently satisfies the Public Float Standard, but believes that if it does not, the redemption of public shares in conjunction with the Extension Vote is what would have caused the Company to no longer be in compliance with the Public Float Standard. If the Company currently does not satisfy the Public Float Standard, it is expected that the surviving company in the Company’s previously announced, pending initial business combination with Cognos Therapeutics Inc. would satisfy the Public Float Standard immediately following the consummation of the initial business combination. The Public Float Notice has no immediate effect on the listing of the Company’s securities, and the Company’s securities continue to trade on the Nasdaq Capital Market. The Company intends to provide Nasdaq, on or prior to July 17, 2023, with the Company’s plan to meet the Public Float Standard, and will evaluate available options to regain compliance with the Public Float Standard. However, there can be no assurance that the Company will be able to regain compliance under the Public Float Standard, or will otherwise be in compliance with other Nasdaq listing criteria.
お知らせ • May 31Nocturne Acquisition Announces Receipt of Second Notification from Nasdaq Due to Failure to File its Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a second notification (the ‘Second Notification’) on May 24, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (‘Nasdaq’) as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the ‘Form 10-Q’), and remaining delinquent in filing its Annual Report on Form 10-K for the period ended December 31, 2022 (the ‘Form 10-K’). The Second Notification advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company has since filed its Form 10-K, and is working diligently to complete and file the Form 10-Q as soon as practicable. In accordance with Nasdaq's letter dated April 21, 2023, the Company has until June 20, 2023, to submit a plan to regain compliance with respect to these delinquent reports. Please note that any Staff exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 16, 2023. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.
お知らせ • May 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/15/2023, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 04Nocturne Acquisition Corporation Receives Non-Compliance Notice From NasdaqOn April 21, 2023, Nocturne Acquisition Corporation (the “Company”) received a notification from Nasdaq that it was in violation of a Nasdaq continued listing requirement as it had failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”). The notification provided that the Company had 60 days from the date of the letter to submit a plan to regain compliance with this continued listing requirement. The Company intends to file its 10-K imminently and bring itself back into compliance with the Nasdaq continued listing requirements.
Board Change • Feb 15High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CFO & Director Thomas Ao is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jan 04Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction.Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation (NasdaqCM:MBTC) for $120 million in a reverse merger transaction on January 3, 2023. Certain outstanding options and warrants to acquire capital stock of Cognos would be assumed by Nocturne. The transaction has been unanimously approved by the respective boards of directors of Cognos and Nocturne and is subject to approval by stockholders of Nocturne and Cognos and other customary closing conditions. The proposed business combination is expected to be completed in the second or third quarter of 2023. Maxim Group LLC served as sole financial advisor to Cognos in connection with the proposed business combination, and Newbridge Securities Corporation provided independent valuation advisory services to Nocturne. Ellenoff Grossman & Schole LLP served as legal advisor to Cognos and Dechert LLP served as legal advisor to Nocturne.
お知らせ • Nov 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 11/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16Nocturne Acquisition Corporation announced delayed 10-Q filingOn 08/15/2022, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 06Nocturne Acquisition Corporation Announces Resignation of Etienne Snyman as Member of the BoardNocturne Acquisition Corporation announced that effective July 4, 2022, Etienne Snyman tendered his resignation as member of the Board. Mr. Snyman resigned due to a disagreement with the Company regarding the completion of the Extension.
お知らせ • Jun 05Nocturne Acquisition Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QNocturne Acquisition Corporation announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Form 10-Q") in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq's continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). The Company is working diligently to complete its Form 10-Q. The Company intends to file it as soon as practicable to regain compliance with Nasdaq continued listing standards.
お知らせ • May 18Nocturne Acquisition Corporation announced delayed 10-Q filingOn 05/17/2021, Nocturne Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.